| 摘要 |
<p>Lipid-modified immune response modifier compounds, pharmaceutical compositio ns containing the compounds and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animal s and in the treatment of diseases including viral and neoplastic diseases, ar e disclosed.</p> |
